CELLforCURE by Seqens
Entity

  • CELLforCURE by Seqens

    Created in 2014
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    1,543

  • Activities

    deeptech manufacturing

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    11 Av. des Tropiques, 91940 Les Ulis, France

    Les Ulis

    France

  • Employees

    Scale: 51-200

    Estimated: 62

  • Engaged corporates

    5
    2 3

  • Added in Motherbase

    1 year ago
Description
  • Value proposition

    Trustworthy development and commercial manufacturing of CELL&GENE therapies

    On december 1st 2023, Seqens completed the acquisition of CELLforCURE.

    Originally a versatile CELL&GENE CDMO, CELLforCURE gained thorough experience in commercial CAR-T cells manufacturing. With 2 200m2 GMP production areas, 6 equipped production suites and 180 seasoned highly skilled experts, CELLforCURE offers versatile and flexible capacities.

    Located in France, 20km away from the Paris Orly Airport, CELLforCURE is an EMA approved production site and is compliant with FDA standards. The site brings analytical, development and regulatory services to serve client needs across the overall product life cycle.

    CELLforCURE teams aim at partnering with innovators to develop and manufacture CELL&GENE therapies for today and tomorrow.

Corporate interactions BETA
Corporate TypeTweets Articles
Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care 		Other

6 Dec 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Other

1 Oct 2024


Région Ile de France
Région Ile de France
National and local authorities, Government Administration
Région Ile de France
National and local authorities, Government Administration 		Other

6 Jul 2024


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing 		Other

3 Apr 2024


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research 		Other

14 Dec 2023


Similar entities
Last news
Show all articles
Social network dynamics